Evidence map›Paper›PMID 21904958›Full record

ArticleMolecular biotechnology2012

Inducible expression of neurotrophic factors by mesenchymal progenitor cells derived from traumatically injured human muscle.

Jamie D Bulken-Hoover, Wesley M Jackson, Youngmi Ji, Jared A Volger, Rocky S Tuan, Leon J Nesti

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biotechnology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Mesenchymal progenitor cells derived from traumatized muscle enhance neurite growth.Journal of tissue engineering and regenerative medicine · 2013
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jamie D Bulken-HooverCartilage Biology and Orthopaedic Branch, Department of Health and Human Services, National Institute of Arthritis and Musculoskeletal and Skin Disease, National Institutes of Health, Bethesda, MD MSC 8022, USA.
Wesley M Jackson
Youngmi Ji
Jared A Volger
Rocky S Tuan
Leon J Nesti
National Institute of Arthritis and Musculoskeletal and Skin Diseases · USWalter Reed Army Institute of Research · USUniversity of Pittsburgh · US

Funding

Pathogenesis of heterotopic ossificationZIAAR041191 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI NESTI, LEON · 2010 to 2014
$3.7M
Intramural NIH HHSNIAMS NIH HHS Z01 AR41131PHS HHS 1ZIAAR041191
6 · The paper itself

Abstract

Peripheral nerve damage frequently accompanies musculoskeletal trauma and repair of these nerves could be enhanced by the targeted application of neurotrophic factors (NTFs), which are typically expressed by endogenous cells that support nerve regeneration. Injured muscle tissues express NTFs to promote reinnervation as the tissue regenerates, but the source of these factors from within the muscles is not fully understood. We have previously identified a population of mesenchymal progenitor cells (MPCs) in traumatized muscle tissue with properties that support tissue regeneration, and our hypothesis was that MPCs also secrete the NTFs that are associated with muscle tissue reinnervation. We determined that MPCs express genes associated with neurogenic function and measured the protein-level expression of specific NTFs with known functions to support nerve regeneration. We also demonstrated the effectiveness of a neurotrophic induction protocol to enhance the expression of the NTFs, which suggests that the expression of these factors may be modulated by the cellular environment. Finally, neurotrophic induction affected the expression of cell surface markers and proliferation rate of the MPCs. Our findings indicate that traumatized muscle-derived MPCs may be useful as a therapeutic cell type to enhance peripheral nerve regeneration following musculoskeletal injury.

Indexed as

Cell ProliferationCells, CulturedCulture MediaGene Expression RegulationHumansImmunohistochemistryMesenchymal Stem CellsMuscle, SkeletalNerve Growth FactorsNerve RegenerationTissue EngineeringTretinoinCulture MediaNerve Growth FactorsTretinoin

Identifiers

PMID21904958
OpenAlexW2140892442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.